Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Diane® is an effective contraceptive that also helps treat acne and mild hair growth issues.

Afatinib often causes skin problems that need proactive management.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Reducing gefitinib dosage improved hair loss, but scarring remained.

A man developed skin issues from cancer medication, which improved with specific treatments.

5-alpha reductase inhibitors do not increase osteoporosis risk in women with certain hair loss conditions.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Eflornithine cream effectively reduces facial hair in women with hirsutism.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

A young patient with unusual insulin resistance and high testosterone levels had a rare INSR gene mutation.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.